According to the data provided in the 10th edition of the IDF Diabetes Atlas in 2021, the number of people diagnosed with diabetes in Uzbekistan reached 1,351,800. The death rate of people with diabetes increased to 3% due to the situation with the COVID-19 pandemic.
It is important to note that within the framework of the National Program for Improving Endocrinological Aid for the Population of the Republic for 2019-2021, new diagnostic and treatment standards have been approved. About 75 thousand patients are provided with insulin free of charge at the expense of the State budget, in the amount of over 40 billion Uzbek So’ms. The material and technical base of 14 regional endocrinological institutions has been strengthened in the amount of more than 200 billion Uzbek So’ms, and provided with modern equipment in the amount of 3.3 million US dollars.
In addition, within two months, the Pharmaceutical Industry Development Agency of the Republic of Uzbekistan took actions to expand activities of domestic manufacturers of special medicines in the field of endocrinology, as well as to establish the production of glucometers and special test strips in the Republic.
Significant work is done in the Republic of Uzbekistan to improve quality of treatment for patients with diabetes mellitus.
